NEW YORK, April 1, 2015 /PRNewswire/ -- CNO Financial
Group (NYSE: CNO) will replace Salix Pharmaceuticals (NASD: SLXP)
in the S&P MidCap 400 after the close of trading on
Monday, April 6. Valeant
Pharmaceuticals (NYSE: VRX) completed the acquisition of Salix
Pharmaceuticals earlier today.
CNO Financial Group is a holding company that sells insurance
throughout the US. Headquartered in Carmel, Indiana, the company will be added to
the S&P MidCap 400 GICS (Global Industry Classification
Standard) Life & Health Insurance Sub-Industry index.
Following is a summary of the change:
S&P MidCap 400
INDEX – April 6, 2015
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
ADDED
|
CNO Financial
Group
|
Financials
|
Life & Health
Insurance
|
DELETED
|
Salix
Pharmaceuticals
|
Health
Care
|
Pharmaceuticals
|
|
Additions to and deletions from S&P Dow Jones Indices
do not in any way reflect an opinion on the investment merits of
the companies involved.
About S&P Dow Jones Indices
S&P Dow Jones Indices LLC, a part of McGraw Hill Financial,
is the world's largest, global resource for index-based concepts,
data and research. Home to iconic financial market indicators, such
as the S&P 500® and the Dow Jones Industrial Average®, S&P
Dow Jones Indices LLC has over 115 years of experience constructing
innovative and transparent solutions that fulfill the needs of
investors. More assets are invested in products based upon our
indices than any other provider in the world. With over 1,000,000
indices covering a wide range of asset classes across the globe,
S&P Dow Jones Indices LLC defines the way investors measure and
trade the markets. To learn more about our company, please visit
www.spdji.com.
S&P® is a registered trademark of Standard & Poor's
Financial Services LLC ("S&P"), a part of McGraw Hill
Financial. Dow Jones® is a registered trademark of Dow Jones
Trademark Holdings LLC ("Dow Jones"). These trademarks have
been licensed to S&P Dow Jones Indices LLC. It is not possible
to invest directly in an index. S&P Dow Jones Indices LLC, Dow
Jones, S&P and their respective affiliates (collectively
"S&P Dow Jones Indices") do not sponsor, endorse, sell, or
promote any investment fund or other investment vehicle that is
offered by third parties and that seeks to provide an investment
return based on the performance of any index. This document does
not constitute an offer of services in jurisdictions where S&P
Dow Jones Indices does not have the necessary licenses. S&P Dow
Jones Indices receives compensation in connection with licensing
its indices to third parties.
For more information:
David Blitzer
Managing Director and Chairman of the Index Committee
S&P Dow Jones Indices
(+1) 212 438 3907
david.blitzer@spdji.com
David R. Guarino
Communications
S&P Dow Jones Indices
(+1) 212 438 1471
dave.guarino@spdji.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cno-financial-group-set-to-join-the-sp-midcap-400-300059792.html
SOURCE S&P Dow Jones Indices